Tetratherix Limited (ASX:TTX)

Market Cap	249.14M
Revenue (ttm)	776.95K
Net Income (ttm)	-5.27M
Shares Out	50.33M
EPS (ttm)	-125.62
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,974
Average Volume	39,992
Open	5.060
Previous Close	5.000
Day's Range	4.800 - 5.130
52-Week Range	2.880 - 5.600
Beta	n/a
RSI	70.22
Earnings Date	n/a

About Tetratherix

Tetratherix Limited engages in biomaterial and regenerative medicine business in Australia and internationally. The company has used its Tetramatrix platform technology to manufacture and provide products in the areas of bone regeneration, tissue spacing, and tissue healing applications. Tetratherix Limited was incorporated in 2015 and is based in Alexandria, Australia.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2015
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: TTX

Financial Performance

In 2024, Tetratherix's revenue was 864,000, an increase of 52.57% compared to the previous year's 566,279. Losses were -4.52 million, 148.3% more than in 2023.